A study of the sequential treatment of acute heart failure with sacubitril/valsartan by recombinant human brain natriuretic peptide: A randomized controlled trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A study of the sequential treatment of acute heart failure with sacubitril/valsartan by recombinant human brain natriuretic peptide: A randomized controlled trial.
- Published In:
- Medicine, 100(16), e25621 (2021)
- Authors:
- Pang, Zhihua, Pan, Chang, Yao, Zhuhua, Ren, Ying, Tian, Liuyang, Cui, Jian, Liu, Ximei, Zhang, Lijun, Chen, Ying
- Database ID:
- RPEP-05663
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05663APA
Pang, Zhihua; Pan, Chang; Yao, Zhuhua; Ren, Ying; Tian, Liuyang; Cui, Jian; Liu, Ximei; Zhang, Lijun; Chen, Ying. (2021). A study of the sequential treatment of acute heart failure with sacubitril/valsartan by recombinant human brain natriuretic peptide: A randomized controlled trial.. Medicine, 100(16), e25621. https://doi.org/10.1097/MD.0000000000025621
MLA
Pang, Zhihua, et al. "A study of the sequential treatment of acute heart failure with sacubitril/valsartan by recombinant human brain natriuretic peptide: A randomized controlled trial.." Medicine, 2021. https://doi.org/10.1097/MD.0000000000025621
RethinkPeptides
RethinkPeptides Research Database. "A study of the sequential treatment of acute heart failure w..." RPEP-05663. Retrieved from https://rethinkpeptides.com/research/pang-2021-a-study-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.